Suppr超能文献

食物对替诺福韦艾米福酰胺药代动力学的影响:一项在健康成年受试者中进行的 I 期、随机、开放标签、两周期交叉试验。

Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects.

机构信息

Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People's Republic of China.

Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, Hangzhou, Zhejiang Province, People's Republic of China.

出版信息

Drug Des Devel Ther. 2023 Oct 9;17:3061-3072. doi: 10.2147/DDDT.S419084. eCollection 2023.

Abstract

PURPOSE

Tenofovir amibufenamide (TMF) is a novel nucleotide reverse transcriptase inhibitor. The aim of this study was to investigate the effect of food on the single-dose pharmacokinetic properties of TMF.

PATIENTS AND METHODS

In this open-label, randomized, crossover study, after an overnight fast, eligible subjects received a single 25 mg dose of TMF tablet, either under fasted conditions or following consumption of a high-fat, high-calorie meal, followed by a two-week washout period. Blood samples were collected until 144 h after administration. TMF and its metabolite, tenofovir (TFV), were analyzed using validated liquid chromatography-tandem mass spectrometry methods. The geometric mean ratio (GMR) and the corresponding 90% confidence interval (CI) values of AUC, AUC, and C were acquired for analysis. The absence of an effect of food was indicated if the 90% CI values were within the predefined equivalence limits of 80%-125%. Safety and tolerability were also assessed.

RESULTS

For TMF, adjusted GMR (90% CI) values for the fed versus fasted states were 150.28% (125.36%-180.16%), 158.24% (130.42%-192.00%), and 57.65% (45.68%-72.76%) for AUC, AUC, and C, respectively. For TFV, the GMR (90% CI) of C was 82.00% (74.30%-90.49%) after administration under fed conditions, slightly outside the bioequivalence boundary of 80%-125%, while the corresponding values for AUC and AUC were within range. The absorption of TMF was delayed by food, with median T values of 0.33 and 1.00 h in fasted and fed conditions, respectively. The adverse events observed in subjects were all mild.

CONCLUSION

Our results demonstrated that TMF tablets were well-tolerated in healthy volunteers. When TMF tablets were taken with food, T was delayed and exposures of TMF and TFV were higher than under fasted conditions. The modest changes observed are not considered clinically relevant, so TMF can be taken with or without food.

摘要

目的

替诺福韦阿米福喷丁(TMF)是一种新型核苷酸逆转录酶抑制剂。本研究旨在考察食物对 TMF 单剂量药代动力学特性的影响。

患者和方法

这是一项开放标签、随机、交叉研究。在禁食过夜后,符合条件的受试者接受单剂量 25mg TMF 片剂,分别在空腹和高脂肪、高热量餐后服用,然后进行两周洗脱期。给药后 144 小时内采集血样。使用经过验证的液相色谱-串联质谱法分析 TMF 和其代谢产物替诺福韦(TFV)。获得 AUC、AUC 和 C 的几何均数比值(GMR)及其相应的 90%置信区间(CI)值。如果 90%CI 值在 80%-125%的预设等效限度内,则表明食物无影响。还评估了安全性和耐受性。

结果

对于 TMF,与空腹相比,进食状态下的调整 GMR(90%CI)值分别为 AUC 的 150.28%(125.36%-180.16%)、AUC 的 158.24%(130.42%-192.00%)和 C 的 57.65%(45.68%-72.76%)。对于 TFV,C 的 GMR(90%CI)值为 82.00%(74.30%-90.49%),在进食状态下给药,略超出 80%-125%的生物等效性边界,而 AUC 和 AUC 的相应值在范围内。食物延迟了 TMF 的吸收,空腹和进食条件下的中位 T 值分别为 0.33 和 1.00 小时。在受试者中观察到的不良反应均为轻度。

结论

我们的结果表明,TMF 片剂在健康志愿者中耐受良好。当 TMF 片剂与食物一起服用时,T 延迟,TMF 和 TFV 的暴露量高于空腹状态。观察到的适度变化不被认为具有临床意义,因此 TMF 可以在有或没有食物的情况下服用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d03/10572397/32e1a113ad4a/DDDT-17-3061-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验